|
USP8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.77789999950195E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.642479999997E-05 |
| Normal-vs-Stage2 |
1.553730E-02 |
| Normal-vs-Stage3 |
1.519410E-03 |
| Normal-vs-Stage4 |
5.354400E-04 |
| Stage1-vs-Stage2 |
9.761200E-01 |
| Stage1-vs-Stage3 |
7.350400E-01 |
| Stage1-vs-Stage4 |
6.470400E-01 |
| Stage2-vs-Stage3 |
8.145400E-01 |
| Stage2-vs-Stage4 |
6.723600E-01 |
| Stage3-vs-Stage4 |
8.044800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.41140000026385E-07 |
| Normal-vs-AfricanAmerican |
6.216500E-04 |
| Normal-vs-Asian |
8.913700E-02 |
| Caucasian-vs-AfricanAmerican |
5.305400E-01 |
| Caucasian-vs-Asian |
5.670800E-01 |
| AfricanAmerican-vs-Asian |
4.266400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.34620003611997E-09 |
| Normal-vs-Female |
7.260300E-02 |
| Male-vs-Female |
6.243100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.857600E-03 |
| Normal-vs-Extreme_Weight |
2.95739999156552E-09 |
| Normal-vs-Obese |
5.202400E-04 |
| Normal-vs-Extreme_Obese |
1.297620E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.512000E-02 |
| Normal_Weight-vs-Obese |
9.687200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.654800E-01 |
| Extreme_Weight-vs-Obese |
4.882300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.576200E-01 |
| Obese-vs-Extreme_Obese |
9.431200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.442980E-03 |
| Normal-vs-Age(41-60Yrs) |
2.418600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.72999999992207E-07 |
| Normal-vs-Age(81-100Yrs) |
2.717400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.510400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.341200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.892800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.796100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.408390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.730000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.48589999485694E-08 |
| Normal-VS-Type2 PRCC |
9.181600E-04 |
| Normal-VS-KIRP CIMP |
2.216500E-04 |
| Normal-VS-Unclassified PRCC |
4.064000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.689800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.049600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.404000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.953200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.938000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.047600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.46749998211726E-09 |
| Normal-vs-N1 |
8.619400E-03 |
| Normal-vs-N2 |
4.821300E-04 |
| N0-vs-N1 |
1.088990E-01 |
| N0-vs-N2 |
5.875000E-01 |
| N1-vs-N2 |
2.866800E-01 |
|
|
